Skip to main content
logo
Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.210
+0.760 (22.03%)
At close: Aug 3, 2026, 4:00 PM EDT
4.300
+0.090 (2.14%)
After-hours: Aug 3, 2026, 7:31 PM EDT

Camp4 Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
3.933.50.650.35-
Revenue Growth
160.53%436.50%86.29%--
Gross Profit
3.933.50.650.35-
Operating Income
-52.53-52.56-53.09-51.88-45
Net Income
-18.33-80.4-51.79-49.29-44.19
Earnings Per Share
-2.36-2.65-11.04-124.80-123.87
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
99.21109.5264.0438.3883.19
Total Debt
2.121.978.4912.1812.4
Net Cash (Debt)
97.09107.5455.5526.270.8
Net Cash Growth
134.74%93.59%112.05%-63.00%-
Net Cash Per Share
2.443.5411.8466.33198.44

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-26.25-29.55-45.56-44.16-38.54
Capital Expenditures
0-0.28-0.44-0.68-4.03
Free Cash Flow
-26.25-29.83-46-44.83-42.57
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
100.00%100.00%100.00%100.00%-
Operating Margin
-1335.18%-1502.43%-8142.33%-14822.60%-
Pretax Margin
-1271.58%-2298.54%-7943.40%-14083.14%-
Profit Margin
-1271.58%-2298.54%-7943.40%-14083.10%-
FCF Margin
-667.21%-852.83%-7055.67%-12809.40%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
53.7990.96161.29--